Amelogenesis Imperfecta and Other Biomineralization Defects in Fam20a and Fam20c Null Mice

Veterinary Pathology

Volumn 49, Issue 6, 2012, Pages 998-1017

  Vogel, P ^a   Hansen, G M ^a   Read, R W ^a   Vance, R B ^a   Thiel, M ^a   Liu, J ^a   Wronski, T J ^b   Smith, D D ^a   Jeter Jones, S ^a   Brommage, R ^a  

^a LEXICON PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

amelogenesis imperfecta; biomineralization; dentin; ectopic mineralization; knockout; osteomalacia; osteosclerosis; phosphatonin; rickets

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM BINDING PROTEIN; ENAMEL PROTEIN; FAM20A PROTEIN, MOUSE; FAM20C PROTEIN, MOUSE; PHOSPHORUS; PROTEIN; SCLEROPROTEIN;

AMELOGENESIS IMPERFECTA; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; FEMALE; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; OSTEOMALACIA; PATHOLOGY; PHENOTYPE; RADIOGRAPHY; RICKETS; TOOTH; TOOTH DEVELOPMENT; VETERINARY;

ALKALINE PHOSPHATASE; AMELOGENESIS IMPERFECTA; ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; DENTAL ENAMEL PROTEINS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOMALACIA; PHENOTYPE; PHOSPHORUS; PROTEINS; RICKETS; TOOTH; TOOTH CALCIFICATION;

EID: 84868686755     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985812453177     Document Type: Article

References (120)

1. Acosta AX,Peres LC,Chimelli LC,et al.Raine dysplasia: a Brazilian case with a mild radiological involvement.Clin Dysmorphol. 2000;9 (2): 99-101.
2. Aldred MJ,Savarirayan R,Crawford PJ.Amelogenesis imperfecta: a classification and catalogue for the 21st century.Oral Dis. 2003;9 (1): 19-23.
3. Alizadeh Naderi AS,Reilly RF.Hereditary disorders of renal phosphate wasting.Nat Rev Nephrol. 2010;6 (11): 657-665.
4. An C,Ide Y,Nagano-Fujii M,et al.A transgenic mouse line with a 58-kb fragment deletion in chromosome 11E1 that encompasses part of the Fam20a gene and its upstream region shows growth disorder.Kobe J Med Sci. 2010;55 (4): E82-92.
5. Backman B,Holm AK.Amelogenesis imperfecta: prevalence and incidence in a northern Swedish county.Community Dent Oral Epidemiol. 1986;14 (1): 43-47.
6. Bai XY,Miao D,Goltzman D,et al.The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency.J Biol Chem. 2003;278 (11): 9843-9849.
7. Bartlett JD,Ganss B.Goldberg M,et al.3. Protein-protein interactions of the developing enamel matrix.Curr Top Dev Biol. 2006;74:57-115.
8. Beck L,Soumounou Y,Martel J,et al.Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice.J Clin Invest. 1997;99 (6): 1200-1209.
9. Benet-Pages A,Lorenz-Depiereux B,Zischka H,et al.FGF23 is processed by proprotein convertases but not by PHEX.Bone. 2004;35 (2): 455-462.
10. Bostrom KI.Cell differentiation in vascular calcification.Z Kardiol. 2000;89 (suppl 2): 69-74.
11. Bucay N,Sarosi I,Dunstan CR,et al.Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.Genes Dev. 1998;12 (9): 1260-1268.
12. Caterina JJ,Skobe Z,Shi J,et al.Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype.J Biol Chem. 2002;277 (51): 49598-49604.
13. Chellaiah MA,Kizer N,Biswas R,et al.Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.Mol Biol Cell. 2003;14 (1): 173-189.
14. Consortium A.Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.Nat Genet. 2000;26 (3): 345-348.
15. Consortium H.A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium.Nat Genet. 1995;11 (2): 130-136.
16. Crawford PJ,Aldred M,Bloch-Zupan A.Amelogenesis imperfecta.Orphanet J Rare Dis. 2007;2:17.
17. D'Amelio P,Isaia G,Isaia GC.The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.J Endocrinol Invest. 2009;32 (suppl 4): 6-9.
18. Daculsi G,Kerebel B.High-resolution electron microscope study of human enamel crystallites: size, shape, and growth.J Ultrastruct Res. 1978;65 (2): 163-172.
19. Daculsi G,Menanteau J,Kerebel LM,et al.Length and shape of enamel crystals.Calcif Tissue Int. 1984;36 (5): 550-555.
20. David V,Martin A,Hedge AM,et al.ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.Am J Physiol Renal Physiol. 2011;300 (3): F783-791.
21. Denecke B,Graber S,Schafer C,et al.Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A.Biochem J. 2003;376 (Pt 1): 135-145.
22. Deutsch D,Palmon A,Dafni L,et al.The enamelin (tuftelin) gene.Int J Dev Biol. 1995;39 (1): 135-143.
23. Du C,Falini G,Fermani S,et al.Supramolecular assembly of amelogenin nanospheres into birefringent microribbons.Science. 2005;307 (5714): 1450-1454.
24. Eames BF,Yan YL,Swartz ME,et al.Mutations in fam20b and xylt1 reveal that cartilage matrix controls timing of endochondral ossification by inhibiting chondrocyte maturation.PLoS Genet. 2011;7 (8): e1002246.
25. Eicher EM,Southard JL,Scriver CR,et al.Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.Proc Natl Acad Sci U S A. 1976;73 (12): 4667-4671.
26. Farrow EG,Davis SI,Ward LM,et al.The role of DMP1 in autosomal recessive hypophosphatemic rickets.J Musculoskelet Neuronal Interact. 2007;7 (4): 310-312.
27. Feng JQ,Ward LM,Liu S,et al.Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.Nat Genet. 2006;38 (11): 1310-1315.
28. Fincham AG,Moradian-Oldak J,Simmer JP.The structural biology of the developing dental enamel matrix.J Struct Biol. 1999;126 (3): 270-299.
29. Foster BL,Tompkins KA,Rutherford RB,et al.Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.Birth Defects Res C Embryo Today. 2008;84 (4): 281-314.
30. Fradin M,Stoetzel C,Muller J,et al.Osteosclerotic bone dysplasia in siblings with a Fam20C mutation.Clin Genet. 2011;80 (2): 177-183.
31. Gajjeraman S,Narayanan K,Hao J,et al.Matrix macromolecules in hard tissues control the nucleation and hierarchical assembly of hydroxyapatite.J Biol Chem. 2007;282 (2): 1193-1204.
32. George A,Hao J.Role of phosphophoryn in dentin mineralization.Cells Tissues Organs. 2005;181 (3-4): 232-240.
33. Gibson CW,Kulkarni AB,Wright JT.The use of animal models to explore amelogenin variants in amelogenesis imperfecta.Cells Tissues Organs. 2005;181 (3-4): 196-201.
34. Gibson CW,Yuan ZA,Hall B,et al.Amelogenin-deficient mice display an amelogenesis imperfecta phenotype.J Biol Chem. 2001;276 (34): 31871-31875.
35. Hansen GM,Markesich DC,Burnett MB,et al.Large-scale gene trapping in C57BL/6 N mouse embryonic stem cells.Genome Res. 2008;18 (10): 1670-1679.
36. Hao J,Narayanan K,Muni T,et al.Dentin matrix protein 4, a novel secretory calcium-binding protein that modulates odontoblast differentiation.J Biol Chem. 2007;282 (21): 15357-15365.
37. Harmey D,Hessle L,Narisawa S,et al.Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.Am J Pathol. 2004;164 (4): 1199-1209.
38. He G,George A.Dentin matrix protein 1 immobilized on type I collagen fibrils facilitates apatite deposition in vitro.J Biol Chem. 2004;279 (12): 11649-11656.
39. Heiss A,DuChesne A,Denecke B,et al.Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.J Biol Chem. 2003;278 (15): 13333-13341.
40. Hessle L,Johnson KA,Anderson HC,et al.Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.Proc Natl Acad Sci U S A. 2002;99 (14): 9445-9449.
41. Ho AM,Johnson MD,Kingsley DM.Role of the mouse ank gene in control of tissue calcification and arthritis.Science. 2000;289 (5477): 265-270.
42. Hu JC,Chun YH,Al Hazzazzi T,et al.Enamel formation and amelogenesis imperfecta.Cells Tissues Organs. 2007;186 (1): 78-85.
43. Hu JC,Hu Y,Smith CE,et al.Enamel defects and ameloblast-specific expression in Enam knock-out/lacz knock-in mice.J Biol Chem. 2008;283 (16): 10858-10871.
44. Hulskamp G,Wieczorek D,Rieder H,et al.Raine syndrome: report of a family with three affected sibs and further delineation of the syndrome.Clin Dysmorphol. 2003;12 (3): 153-160.
45. Hunter GK,Hauschka PV,Poole AR,et al.Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.Biochem J. 1996;317 (Pt 1): 59-64.
46. Imel EA,Hui SL,Econs MJ.FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.J Bone Miner Res. 2007;22 (4): 520-526.
47. Iwasaki K,Bajenova E,Somogyi-Ganss E,et al.Amelotin-a novel secreted, ameloblast-specific protein.J Dent Res. 2005;84 (12): 1127-1132.
48. Johnson K,Polewski M,van Etten D,et al.Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice.Arterioscler Thromb Vasc Biol. 2005;25 (4): 686-691.
49. Ketteler M,Bongartz P,Westenfeld R,et al.Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.Lancet. 2003;361 (9360): 827-833.
50. Koike T,Izumikawa T,Tamura J,et al.FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region.Biochem J. 2009;421 (2): 157-162.
51. Krebsbach PH,Lee SK,Matsuki Y,et al.Full-length sequence, localization, and chromosomal mapping of ameloblastin. A novel tooth-specific gene.J Biol Chem. 1996;271 (8): 4431-4435.
52. Liu S,Tang W,Zhou J,et al.Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.Am J Physiol Endocrinol Metab. 2007;293 (6): E1636-1644.
53. Lomashvili KA,Khawandi W,O'Neill WC.Reduced plasma pyrophosphate levels in hemodialysis patients.J Am Soc Nephrol. 2005;16 (8): 2495-2500.
54. Lorenz-Depiereux B,Bastepe M,Benet-Pages A,et al.DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.Nat Genet. 2006;38 (11): 1248-1250.
55. Lorenz-Depiereux B,Schnabel D,Tiosano D,et al.Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.Am J Hum Genet. 2010;86 (2): 267-272.
56. Lu Y,Papagerakis P,Yamakoshi Y,et al.Functions of KLK4 and MMP-20 in dental enamel formation.Biol Chem. 2008;389 (6): 695-700.
57. Luo G,Ducy P,McKee MD,et al.Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein.Nature. 1997;386 (6620): 78-81.
58. Mackenzie NC,Zhu D,Milne EM,et al.Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice.PLoS One. 2012;7 (2): e32177.
59. Mahafza T,El-Shanti H,Omari H.Raine syndrome: report of a case with hand and foot anomalies.Clin Dysmorphol. 2001;10 (3): 227-229.
60. Martin A,Liu S,David V,et al.Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.FASEB J. 2011;25 (8): 2551-2562.
61. Meyer JL.Can biological calcification occur in the presence of pyrophosphate?.Arch Biochem Biophys. 1984;231 (1): 1-8.
62. Morava E,Kuhnisch J,Drijvers JM,et al.Autosomal recessive mental retardation, deafness, ankylosis, and mild hypophosphatemia associated with a novel ANKH mutation in a consanguineous family.J Clin Endocrinol Metab. 2011;96 (1): E189-198.
63. Munroe PB,Olgunturk RO,Fryns JP,et al.Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome.Nat Genet. 1999;21 (1): 142-144.
64. Murshed M,McKee MD.Molecular determinants of extracellular matrix mineralization in bone and blood vessels.Curr Opin Nephrol Hypertens. 2010;19 (4): 359-365.
65. Nalbant D,Youn H,Nalbant SI,et al.FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells.BMC Genomics. 2005;6:11.
66. Nanci ATen Cate's Oral Histology: Development, Structure, and Function. 7th ed. St. Louis, MO: Mosby Elsevier; 2008:141-190.Nanci A, ed. St. Louis, MO: Mosby Elsevier; 2008:141-190.
67. Narayanan K,Ramachandran A,Hao J,et al.Dual functional roles of dentin matrix protein 1. Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store.J Biol Chem. 2003;278 (19): 17500-17508.
68. Nusier M,Yassin O,Hart TC,et al.Phenotypic diversity and revision of the nomenclature for autosomal recessive amelogenesis imperfecta.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97 (2): 220-230.
69. O'Sullivan J,Bitu CC,Daly SB,et al.Whole-exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome.Am J Hum Genet. 2011;88 (5): 616-620.
70. Opsahl Vital S,Gaucher C,Bardet C,et al.Tooth dentin defects reflect genetic disorders affecting bone mineralization.Bone. 2012;50 (4): 989-997.
71. Raine J,Winter RM,Davey A,et al.Unknown syndrome: microcephaly, hypoplastic nose, exophthalmos, gum hyperplasia, cleft palate, low set ears, and osteosclerosis.J Med Genet. 1989;26 (12): 786-788.
72. Razzaque MS,Lanske B.The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.J Endocrinol. 2007;194 (1): 1-10.
73. Riser BL,Barreto FC,Rezg R, et alNephrol Dial Transplant. 2011:.
74. Rowe PS.Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.Crit Rev Eukaryot Gene Expr. 2012;22 (1): 61-86.
75. Rutsch F,Ruf N,Vaingankar S,et al.Mutations in ENPP1 are associated with "idiopathic" infantile arterial calcification.Nat Genet. 2003;34 (4): 379-381.
76. Saito T,Arsenault AL,Yamauchi M,et al.Mineral induction by immobilized phosphoproteins.Bone. 1997;21 (4): 305-311.
77. Santos MC,Hart PS,Ramaswami M,et al.Exclusion of known gene for enamel development in two Brazilian families with amelogenesis imperfecta.Head Face Med. 2007;3:8.
78. Schafer C,Heiss A,Schwarz A,et al.The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.J Clin Invest. 2003;112 (3): 357-366.
79. Schiavi SC.Bone talk.Nat Genet. 2006;38 (11): 1230-1231.
80. Schinke T,Amendt C,Trindl A,et al.The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis.J Biol Chem. 1996;271 (34): 20789-20796.
81. Schofield PN,Vogel P,Gkoutos GV,et al.Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice.Dis Model Mech. 2012;5 (1): 19-25.
82. Schoppet M,Preissner KT,Hofbauer LC.RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.Arterioscler Thromb Vasc Biol. 2002;22 (4): 549-553.
83. Shimada T,Mizutani S,Muto T,et al.Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.Proc Natl Acad Sci U S A. 2001;98 (11): 6500-6505.
84. Simmer JP,Hu Y,Lertlam R,et al.Hypomaturation enamel defects in Klk4 knockout/LacZ knockin mice.J Biol Chem. 2009;284 (28): 19110-19121.
85. Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.Cell. 1997;89 (2): 309-319.
86. Simpson MA,Hsu R,Keir LS,et al.Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development.Am J Hum Genet. 2007;81 (5): 906-912.
87. Simpson MA,Scheuerle A,Hurst J,et al.Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia.Clin Genet. 2009;75 (3): 271-276.
88. Smith CE.Cellular and chemical events during enamel maturation.Crit Rev Oral Biol Med. 1998;9 (2): 128-161.
89. Smith CE,Richardson AS,Hu Y,et al.Effect of kallikrein 4 loss on enamel mineralization: Comparison with mice lacking matrix metalloproteinase 20.J Biol Chem. 2011;286 (20): 18149-18160.
90. Smith CE,Wazen R,Hu Y,et al.Consequences for enamel development and mineralization resulting from loss of function of ameloblastin or enamelin.Eur J Oral Sci. 2009;117 (5): 485-497.
91. Snead ML,Lau EC,Fincham AG,et al.Of mice and men: anatomy of the amelogenin gene.Connect Tissue Res. 1989;22 (1-4): 101-109.
92. Speer MY,McKee MD,Guldberg RE,et al.Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.J Exp Med. 2002;196 (8): 1047-1055.
93. Spicer SS,Lewis SE,Tashian RE,et al.Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification.Am J Pathol. 1989;134 (4): 947-954.
94. Steitz SA,Speer MY,McKee MD,et al.Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.Am J Pathol. 2002;161 (6): 2035-2046.
95. Strewler GJ.FGF23, hypophosphatemia, and rickets: has phosphatonin been found?.Proc Natl Acad Sci U S A. 2001;98 (11): 5945-5946.
96. Strom TM,Francis F,Lorenz B,et al.Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia.Hum Mol Genet. 1997;6 (2): 165-171.
97. Strom TM,Juppner H. PHEX.FGF23, DMP1 and beyond.Curr Opin Nephrol Hypertens. 2008;17 (4): 357-362.
98. Suliman ME,Garcia-Lopez E,Anderstam B,et al.Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.Adv Clin Chem. 2008;46:217-262.
99. Szweras M,Liu D,Partridge EA,et al.Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling.J Biol Chem. 2002;277 (22): 19991-19997.
100. Tagliabracci VS,Engel JL,Wen J,et al.Secreted kinase phosphorylates extracellular proteins that regulate biomineralization.Science. 2012;336:1150-1153.
101. Towler DA.Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype.Arterioscler Thromb Vasc Biol. 2005;25 (4): 651-654.
102. Triffitt JT,Gebauer U,Ashton BA,et al.Origin of plasma alpha2HS-glycoprotein and its accumulation in bone.Nature. 1976;262 (5565): 226-227.
103. Urzua B,Ortega-Pinto A,Morales-Bozo I,et al.Defining a new candidate gene for amelogenesis imperfecta: from molecular genetics to biochemistry.Biochem Genet. 2011;49 (1-2): 104-121.
104. Villa-Bellosta R,Wang X,Millan JL,et al.Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle.Am J Physiol Heart Circ Physiol. 2011;301 (1): H61-68.
105. Vogel P,Read RW,Vance RB,et al.Ocular albinism and hypopigmentation defects in Slc24a5-/- mice.Vet Pathol. 2008;45 (2): 264-279.
106. Wada T,McKee MD,Steitz S,et al.Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.Circ Res. 1999;84 (2): 166-178.
107. Wallwork ML,Kirkham J,Chen H,et al.Binding of dentin noncollagenous matrix proteins to biological mineral crystals: an atomic force microscopy study.Calcif Tissue Int. 2002;71 (3): 249-255.
108. Wang X,Hao J,Xie Y,et al.Expression of FAM20C in the osteogenesis and odontogenesis of mouse.J Histochem Cytochem. 2010;58 (11): 957-967.
109. Wang X,Wang S,Li C,et al.Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice.PLoS Genet. 2012;8 (5): e1002708.
110. Wattler S,Kelly M,Nehls M.Construction of gene targeting vectors from lambda KOS genomic libraries.Biotechniques. 1999 1150-1156;26 (6): 1158.
111. Wazen RM,Moffatt P,Zalzal SF,et al.A mouse model expressing a truncated form of ameloblastin exhibits dental and junctional epithelium defects.Matrix Biol. 2009;28 (5): 292-303.
112. Weber TJ,Liu S,Indridason OS,et al.Serum FGF23 levels in normal and disordered phosphorus homeostasis.J Bone Miner Res. 2003;18 (7): 1227-1234.
113. Weiss MJ,Cole DE,Ray K,et al.A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia.Proc Natl Acad Sci U S A. 1988;85 (20): 7666-7669.
114. White KE,Carn G,Lorenz-Depiereux B,et al.Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.Kidney Int. 2001;60 (6): 2079-2086.
115. Whyte MP.Physiological role of alkaline phosphatase explored in hypophosphatasia.Ann N Y Acad Sci. 2010;1192:190-200.
116. Witkop CJ.Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification.J Oral Pathol. 1988;17 (9-10): 547-553.
117. Xiao ZS,Crenshaw M,Guo R,et al.Intrinsic mineralization defect in Hyp mouse osteoblasts.Am J Physiol. 1998;275 (4 Pt 1): E700-708.
118. Yamazaki Y,Okazaki R,Shibata M,et al.Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.J Clin Endocrinol Metab. 2002;87 (11): 4957-4960.
119. Ye L,MacDougall M,Zhang S,et al.Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development.J Biol Chem. 2004;279 (18): 19141-19148.
120. Zambrowicz BP,Abuin A,Ramirez-Solis R,et al.Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.Proc Natl Acad Sci U S A. 2003;100 (24): 14109-14114.